✕
Free ₹200 worth HealthCash on app
Use HealthCash to order medicines, health products & much more
Polidocanol
Confused about any medicine? Just ask Practo AIFREE
50000+ health queries resolved in last month
Chat with Practo AI on Whatsapp
Not finding what you need? Ask Practo AI
FREE
Chat with Practo AI on Whatsapp
Description
Polidocanol is used for the treatment of uncomplicated spider veins (varicose veins ≤1 mm in diameter) and uncomplicated reticular veins (varicose veins 1 to 3 mm in diameter) in the legs, a condition where the veins become large, twisted and swollen when the vein valves do not work properly. This medicine is not recommended for use in patients less than 18 years of age.
QUICK LINKS:
Side effects
Major & minor side effects for Polidocanol
Bleeding
Severe pain, burning, or irritation in legs
Discoloration of the skin
Severe headache
Itching
Swelling, warmth, or redness in one or both legs
Numbness
Dizziness
Swelling and redness at the injection site
Trouble breathing
Uses of Polidocanol
What is it prescribed for?
Varicose veins
This medicine is used for the treatment of uncomplicated spider veins (varicose veins ≤1 mm in diameter) and uncomplicated reticular veins (varicose veins 1 to 3 mm in diameter) in the legs, a condition where the veins become large, twisted and swollen when the vein valves do not work properly.
Concerns
Commonly asked questions
Onset of action
The amount of time required for this medicine to show its action is not clinically established.Duration of effect
The amount of time for which this medicine remains active in the body is not clinically established.Safe with alcohol?
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.Is it habit forming?
No habit-forming tendencies were reported.Usage in pregnancy?
This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.Usage while breast-feeding?
This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine. If the medicine is used, close monitoring of the infant for any undesired side effects is recommended.
Allergy
This medicine is not recommended for use if you have a known allergy to Polidocanol or any other inactive ingredients present along with it.
Acute thromboembolic disease
This medicine is not recommended for use in patients with acute thromboembolic diseases, a condition of formation of blood clot in the blood vessels due to the increased risk of worsening of the patient's condition.
Thrombophilia
This medicine is not recommended for use in patients with thrombophilia (blood coagulation abnormality) due to the increased risk of worsening of the patient's condition.
Warnings for special population
Pregnancy
This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
Breast-feeding
This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine. If the medicine is used, close monitoring of the infant for any undesired side effects is recommended.
General warnings
Venous thrombosis
This medicine may cause venous thrombosis (clot formation within a vein) or other thrombotic events and should be used with extreme caution in patients with a history of deep vein thrombosis (clot formation in a deep vein), recent (within 3 months) major surgery, or prolonged hospitalization due to the increased risk for developing a blood clot. Close monitoring of clinical condition, appropriate dose adjustments or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.
Use in children
This medicine is not recommended for use in patients less than 18 years of age since the safety and efficacy of use are not clinically established.
Anaphylactic reactions
This medicine may cause severe allergic reactions, including anaphylactic shock in some patients. Appropriate corrective treatments, dose adjustments or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.
Extravasation
This medicine has to be administered very carefully to avoid extravasation, as this can cause severe tissue necrosis.
Missed Dose
Since this medicine is administered in the hospital or clinic setting by a qualified healthcare professional, the likelihood of a missed dose is very low.
Overdose
Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol
Description
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Instructions
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine
Propylene Glycol
Peginterferon Alfa-2B
Disease interactions
Disease
Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
This medicine should be administered by a qualified healthcare professional in the clinical or hospital setting. Inform the doctor if you have a known history of allergy to this medicine. Report to the doctor all your current medicines as well as your medical conditions before receiving this medicine. Report any undesirable side effects to the doctor promptly.
Miscelleneous
How it works
This medicine increases the formation of blood clots and scar tissue inside the veins and thus immediately helps to shrink the enlarged veins.
Legal Status
Classification
Category
Sclerosing agents
Schedule
Schedule H
Polidocanol - DrugBank [Internet]. Drugbank.ca. 2019 [cited 2 January 2019]. Available from:
Polidocanol [Internet]. Pubchem.ncbi.nlm.nih.gov. 2019 [cited 2 January 2019]. Available from:
[Internet]. Accessdata.fda.gov. 2019 [cited 2 January 2019]. Available from:
[Internet]. Pdf.hres.ca. 2019 [cited 2 January 2019]. Available from:
[Internet]. Btgplc.com. 2019 [cited 2 January 2019]. Available from:
DailyMed - Asclera - polidocanol injection, solution [Internet]. Dailymed.nlm.nih.gov. 2019 [cited 2 January 2019]. Available from:
Information on this page was last updated on 4 Feb 2019
Disclaimer
We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.